(IN BRIEF) Researchers at the University of Helsinki and HUS Helsinki University Hospital have developed a groundbreaking technique to control cell proliferation, enhancing the safety and efficacy of cell therapies. Published in Molecular Therapy, the study details how modified stem … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Science, Security & Safety, Technology
Tagged cell therapies, Controlled Proliferation Cells, Docent Kirmo Wartiovaara, HUS Helsinki University Hospital, partnership, Rocio Sartori Maldonado, safety, University of Helsinki
(IN BRIEF) AstraZeneca and Quell Therapeutics have announced a collaboration to develop innovative treatments for Type 1 Diabetes and Inflammatory Bowel Disease. Quell’s T-regulatory cell engineering technology will be used to create potential curative therapies. AstraZeneca has the option to … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, United Kingdom
Tagged AstraZeneca, autoimmune disease, cell therapies, Foxp3 Phenotype Lock, Iain McGill, IBD, IND, inflammatory bowel disease, Investigational New Drug, Mene Pangalos, multi-modular Treg cell therapy, Quell, Quell Therapeutics, T-regulator, T-regulatory cell engineering, T1D, Treg, type 1 diabetes
(PRESS RELEASE) GENEVA, 28-Oct-2021 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the expansion of its Glasgow biosafety testing facility thus helping to accelerate quality testing and reduce turnaround time for its clients. The … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Archie Lovatt, biological medicines, biologics, biologics manufacturers, biopharmaceutical, Biosafety Center of Excellence, BSL-2 cabinets, cell culture, cell therapies, COVID-19 vaccine, drug development, ELISA, gene therapies, Glasgow, Good Laboratory Practices, Good Manufacturing Practices, laboratories, monoclonal antibodies, polymerase chain reaction, real-time PCR testing, SGS, vaccines, virus detection
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?